Surface Transforms PLC
31 March 2003
Surface Transforms PLC (the 'Company')
31 March 2003
Directorate Change - Additional Information
Further to the announcement on 27 March 2003 relating to the appointment of
Kevin D'Silva as a non-executive director of Surface Transforms PLC, the Company
releases the following additional information.
Ferraris Group plc is quoted on the Official List of the London Stock Exhange.
All other companies listed below are subsidiaries of Ferraris Group plc.
Full Name: Kevin Alphonso D'Silva
Age: 52
Current Ferraris Group plc
Directorships: Ferraris Healthcare Limited
Ferraris Medical Limited
N H Eastwood & Son Limited
Dutch Sensor Technologie Limited
Hertford Medical International Limited
Instrument Technology Limited
Morgan Medical Limited
Oxford Cryosystems Limited
PDS Research UK Limited
Reynolds Medical Group Limited
Reynolds Medical Limited
RGS (1) plc
Stainless Metalcraft (Chatteris) Limited
Univak plc
Univac Limited
Unirax Systems Limited
Services Supports Limited
RG One Limited
RGS(2) Limited
RGS(3) Limited
RGS(4) Limited
RGS(5) Limited
RGS(6) Limited
RE Limited
RF(1) Limited
Intervak Limited
Intervac Limited
Foundation Network Systems Limited
Densa Limited
Quantum Research UK Limited
Ferraris Instruments Limited
Ferraris Development and Engineering Company Limited
Clinical and Scientific Equipment Limited
P K Morgan Limited
Metalcraft Pipework and Fabrications Limited
WSA Engineering Limited
Ferraris Group Inc, Colorado,USA
Ferraris Medical Inc, USA
Collins Medical Inc, USA
Reynolds Medical Inc, USA
Del Mar Medical Systems Inc,USA
Oxford Cryosystems Inc, USA
Pulmonary Data Systems Inc, USA
Pulmonary Data Systems Research Inc, USA
Ferraris Cardio Pulmonary Inc, USA
Current KDS Associates
Partnerships:
Save as set out above, there is no further information to disclose in respect of
Kevin D'Silva under paragraph (f) of schedule two to the AIM Rules.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.